Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma.

Rajnai H, Bödör C, Balogh Z, Gagyi E, Csomor J, Krenács T, Tóth E, Matolcsy A.

Histopathology. 2012 May;60(6B):E66-75. doi: 10.1111/j.1365-2559.2012.04187.x. Epub 2012 Mar 6.

PMID:
22394030
2.

Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients.

Alvaro T, Lejeune M, Salvadó MT, Lopez C, Jaén J, Bosch R, Pons LE.

J Clin Oncol. 2006 Dec 1;24(34):5350-7.

PMID:
17135637
3.

Clonal selection in the bone marrow involvement of follicular lymphoma.

Bognár A, Csernus B, Bödör C, Reiniger L, Szepesi A, Tóth E, Kopper L, Matolcsy A.

Leukemia. 2005 Sep;19(9):1656-62.

PMID:
15973453
4.

gammadelta T lymphocytes count is normal and expandable in peripheral blood of patients with follicular lymphoma, whereas it is decreased in tumor lymph nodes compared with inflammatory lymph nodes.

Braza MS, Caraux A, Rousset T, Lafaye de Micheaux S, Sicard H, Squiban P, Costes V, Klein B, Rossi JF.

J Immunol. 2010 Jan 1;184(1):134-40. doi: 10.4049/jimmunol.0901980. Epub 2009 Nov 30.

5.

Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.

Richendollar BG, Pohlman B, Elson P, Hsi ED.

Hum Pathol. 2011 Apr;42(4):552-7. doi: 10.1016/j.humpath.2010.08.015. Epub 2011 Jan 15.

PMID:
21237493
6.

A unifying microenvironment model in follicular lymphoma: outcome is predicted by programmed death-1--positive, regulatory, cytotoxic, and helper T cells and macrophages.

Wahlin BE, Aggarwal M, Montes-Moreno S, Gonzalez LF, Roncador G, Sanchez-Verde L, Christensson B, Sander B, Kimby E.

Clin Cancer Res. 2010 Jan 15;16(2):637-50. doi: 10.1158/1078-0432.CCR-09-2487. Epub 2010 Jan 12.

7.

Flow cytometry in the bone marrow evaluation of follicular and diffuse large B-cell lymphomas.

Palacio C, Acebedo G, Navarrete M, Ruiz-Marcellán C, Sanchez C, Blanco A, López A.

Haematologica. 2001 Sep;86(9):934-40.

8.

Detection of t(14;18) by PCR of IgH/BCL2 fusion gene in follicular lymphoma from archived cytological smears.

Stoos-Veić T, Livun A, Ajduković R, Pejsa V, Jaksić O, Kusec R.

Coll Antropol. 2010 Jun;34(2):425-9.

PMID:
20698113
9.

T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?

Raynaud P, Caulet-Maugendre S, Foussard C, Salles G, Moreau A, Rossi JF, Patey M, Rousselet MC, Bene MC, Damotte D, Cornillet Lefebvre P, Martin A, Costes V; GOELAMS group..

Hum Pathol. 2008 Feb;39(2):194-200. Epub 2007 Oct 18.

PMID:
17949786
10.

Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome.

Lee AM, Clear AJ, Calaminici M, Davies AJ, Jordan S, MacDougall F, Matthews J, Norton AJ, Gribben JG, Lister TA, Goff LK.

J Clin Oncol. 2006 Nov 1;24(31):5052-9. Epub 2006 Oct 10.

PMID:
17033038
11.

Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study.

Laurent C, Müller S, Do C, Al-Saati T, Allart S, Larocca LM, Hohaus S, Duchez S, Quillet-Mary A, Laurent G, Brousset P, Valitutti S.

Blood. 2011 Nov 17;118(20):5371-9. doi: 10.1182/blood-2011-04-345777. Epub 2011 Aug 19.

12.

Bone marrow involvement in T-cell-rich B-cell lymphoma.

Skinnider BF, Connors JM, Gascoyne RD.

Am J Clin Pathol. 1997 Nov;108(5):570-8.

PMID:
9353097
13.

Distinct features of angioimmunoblastic T-cell lymphoma with bone marrow involvement.

Cho YU, Chi HS, Park CJ, Jang S, Seo EJ, Huh J.

Am J Clin Pathol. 2009 May;131(5):640-6. doi: 10.1309/AJCPQXKCHQH4VAJ5.

PMID:
19369622
14.

[Evaluation of tumor vascularization and microenvironment in follicular lymphoma].

Nesterova ES, Kravchenko SK, Gemdzhian ÉG, Osmanov EA, Kovrigina AM.

Ter Arkh. 2013;85(7):57-64. Russian.

PMID:
24137948
15.

Prognostic value of bone marrow involvement by clonal immunoglobulin gene rearrangements in follicular lymphoma.

Berget E, Helgeland L, Liseth K, Løkeland T, Molven A, Vintermyr OK.

J Clin Pathol. 2014 Dec;67(12):1072-7. doi: 10.1136/jclinpath-2014-202382. Epub 2014 Sep 18.

16.

Bone marrow involvement in follicular lymphoma: comparison of histology and flow cytometry as staging procedures.

Schmidt B, Kremer M, Götze K, John K, Peschel C, Höfler H, Fend F.

Leuk Lymphoma. 2006 Sep;47(9):1857-62.

PMID:
17064998
17.

Detection of clonal CD34+19+ progenitors in bone marrow of BCL2-IgH-positive follicular lymphoma patients.

Macintyre EA, Belanger C, Debert C, Canioni D, Turhan AG, Azagury M, Hermine O, Varet B, Flandrin G, Schmitt C.

Blood. 1995 Dec 15;86(12):4691-8.

18.

A molecular analysis of biclonal follicular lymphoma: further evidence for bone marrow origin and clonal selection.

Nakamura Y, Sato Y, Yoshida K, Kakegawa E, Ito Y, Seyama A, Kayano H, Bessho M.

Eur J Haematol. 2009 May;82(5):398-403. doi: 10.1111/j.1600-0609.2009.01233.x. Epub 2009 Feb 5.

19.

Polymerase chain reaction detection of cells carrying t(14;18) in bone marrow of patients with follicular and diffuse large B-cell lymphoma: the importance of analysis at diagnosis and significance of long-term follow-up.

Papajík T, Jedlicková K, Kriegová E, Jarosová M, Raida L, Faber E, Hubácek J, Vondráková J, Pikalová Z, Indrák K.

Neoplasma. 2001;48(6):501-5.

PMID:
11949845
20.

High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.

Carreras J, Lopez-Guillermo A, Roncador G, Villamor N, Colomo L, Martinez A, Hamoudi R, Howat WJ, Montserrat E, Campo E.

J Clin Oncol. 2009 Mar 20;27(9):1470-6. doi: 10.1200/JCO.2008.18.0513. Epub 2009 Feb 17.

PMID:
19224853

Supplemental Content

Support Center